IPP Bureau
Trivitron Healthcare elevates Chandra Ganjoo to Group CEO
By IPP Bureau - March 22, 2022
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Kypros Nicolaides Fetal Medicine centre opens in Abu Dhabi
By IPP Bureau - March 22, 2022
Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia
Hester Biosciences foray into pet care industry
By IPP Bureau - March 22, 2022
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health
By IPP Bureau - March 22, 2022
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
MFine brings Blood Pressure and Glucose Monitoring on smartphones
By IPP Bureau - March 22, 2022
Enables millions of Indians to monitor their vitals without the need of any additional device
Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022
By IPP Bureau - March 22, 2022
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
NIBIOHN identifies tissue-specific exosome marker candidates from blood
By IPP Bureau - March 22, 2022
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
By IPP Bureau - March 22, 2022
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Barentz acquires life science ingredients, specialty chemicals distributor Divsa
By IPP Bureau - March 22, 2022
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Mandaviya launches BRICS vaccine R&D centre
By IPP Bureau - March 22, 2022
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Glenmark receives ANDA approval for Lacosamide tablets
By IPP Bureau - March 21, 2022
The company plans to launch the product immediately
USFDA approves Perrigo’s Nasonex
By IPP Bureau - March 21, 2022
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
Genomic data opened to researchers
By IPP Bureau - March 21, 2022
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Biological Dynamics study demonstrates detection of early-stage cancers
By IPP Bureau - March 21, 2022
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
physIQ and CellCarta collaborate to personalise vaccine development
By IPP Bureau - March 21, 2022
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
